Titan Pharmaceuticals, Inc. Ownership
$4.61
0.00%
Nasdaq, Fri, Sep 25 2026.
Index
Industry
Titan Pharmaceuticals, Inc. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Blue Harbour Asset Management L.L.C
|
265.913k | 19.99% | +265.913k | Jul 18 2025 |
| 2 |
Choong (Choon Hau)
|
241.531k | 18.16% | — | Jul 18 2025 |
| 3 |
Chung (Jeffrey)
|
150.087k | 11.28% | +6.250k | Jul 18 2025 |
| 4 |
Fidelity Management & Research Company LLC
|
0.000 | 0.00% | -1.000 | Sep 30 2024 |
| 5 |
MCF Advisors LLC
|
0.000 | 0.00% | -165.000 | Mar 31 2025 |
|
1
Blue Harbour Asset Management L.L.C
|
19.99%
265.913k
|
|
2
Choong (Choon Hau)
|
18.16%
241.531k
|
|
3
Chung (Jeffrey)
|
11.28%
150.087k
|
|
4
Fidelity Management & Research Company LLC
|
0.00%
0.000
|
|
5
MCF Advisors LLC
|
0.00%
0.000
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 49.44% of Titan Pharmaceuticals, Inc., with Blue Harbour Asset Management L.L.C the biggest at 19.99%, followed by Choong (Choon Hau) (18.16%) and Chung (Jeffrey) (11.28%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
